Global retirement and discontinuation of Trifecta™ family of bioprosthetic heart valves due to early Structural Valve Deterioration
Healthcare professional
Industry member
Medical devices
12 September 2023
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
A Dear Healthcare Professional Letter has been issued by Abbott Medical (Singapore) Pte. Ltd. to inform healthcare professionals of the global retirement and discontinuation of the Trifecta™ family of bioprosthetic heart valves due to the potential risk of early Structural Valve Deterioration (SVD). Patient management considerations previously provided in the March 2023 communication remain in effect and are appended with this communication. Please refer to the letter for details.
Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of these letters can be found in the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://hpp.moh.gov.sg and follow the procedures below to access the MOH Alert system.
Step 1: Select your profession under ‘For Healthcare Professionals’.
Step 2: Click on ‘Useful links’.
Step 3: Click on ‘MOH Alert’ and log in via Singpass.
Step 4: Click on ‘Drug Alerts’ or ‘Med Device Alerts’ to view the DHCPLs.
